Clinical Trials Browser

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Lung Neoplasms, Melanoma, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT04045522 2021-07-20

Study on Bisphosphonates Targeting Triple-negative Breast Cancer

Unknown

120 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04669522 2020-12-17

PSY-ONC TNBC

Unknown

50 enrolled

Breast

Triple Negative Breast Neoplasms

NCT03617341 2020-10-27

Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer

Unknown

200 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04362462 2020-04-27

Molecular Profiling After Neoadjuvant Chemotherapy for Triple-negative Breast Cancer

Unknown

120 enrolled

Breast

Triple Negative Breast Neoplasms

NCT03164863 2020-01-13

Onco4D(TM) Biodynamic Chemotherapy Selection for Breast Cancer Patients

Unknown

150 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04145947 2019-11-18

Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients

Unknown

200 enrolled

Breast

Triple Negative Breast Neoplasms

NCT03332368 2017-11-07

Clinical Study on Triple Negative Breast Cancer With Chinese Medicine

Unknown

620 enrolled

Breast

Recurrence, Triple Negative Breast Neoplasms

NCT02639832 2016-08-08

A Pilot Surveillance Study to Monitor Natural Killer Cells and Circulating Tumor Cells in Women With Previously Treated Non-metastatic Triple Negative Breast Cancer and Women With Previously Treated Non-metastatic Breast Cancer With a Confirmed BRCA Mutation.

Unknown

210 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01514565 2015-03-18

Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer

Unknown

70 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02012634 2014-11-13

MACRO

Unknown

340 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00897728 2010-12-01

Study of Tumor and Blood Samples From Women With Breast Cancer

Unknown

180 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

A-TRAIN

NEORISK

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

PERSONA

Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

HERMIONE-10

TIP

Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical Trials

Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma

CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NAC

A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.

Study on Bisphosphonates Targeting Triple-negative Breast Cancer

PSY-ONC TNBC

Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer

Molecular Profiling After Neoadjuvant Chemotherapy for Triple-negative Breast Cancer

Onco4D(TM) Biodynamic Chemotherapy Selection for Breast Cancer Patients

Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients

Clinical Study on Triple Negative Breast Cancer With Chinese Medicine

A Pilot Surveillance Study to Monitor Natural Killer Cells and Circulating Tumor Cells in Women With Previously Treated Non-metastatic Triple Negative Breast Cancer and Women With Previously Treated Non-metastatic Breast Cancer With a Confirmed BRCA Mutation.

Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer

MACRO

Study of Tumor and Blood Samples From Women With Breast Cancer